{
    "title": "Biotech company CureVac aims to raise up to $245 mln in U.S. IPO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8612635/Biotech-company-CureVac-aims-raise-245-mln-U-S-IPO.html",
    "date": "2020-08-10",
    "keywords": [
        "vaccine",
        "curevac",
        "development",
        "covid19",
        "ipo",
        "cofounder",
        "market",
        "frankfurt",
        "germanys",
        "offering",
        "biotech",
        "firm",
        "monday",
        "total",
        "majority",
        "owner",
        "dietmar",
        "software",
        "giant",
        "sap",
        "midpoint",
        "price",
        "range",
        "company",
        "debut",
        "friday",
        "transaction",
        "midjune",
        "biontech",
        "partner",
        "pfizer",
        "end",
        "pandemic",
        "world",
        "health",
        "organization",
        "curevacs",
        "rampup",
        "manufacturing",
        "drug",
        "statement",
        "group",
        "foundation",
        "bill",
        "july",
        "state",
        "drugmaker",
        "glaxosmithkline",
        "qatar",
        "investment",
        "authority",
        "growth",
        "stock",
        "listing",
        "overallotment",
        "option",
        "demand",
        "bank",
        "credit",
        "berenberg",
        "bookrunning",
        "burger",
        "arno",
        "schuetze",
        "patricia",
        "weiss",
        "editing",
        "michelle",
        "martin",
        "macfie"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}